Menu Back toSession-9-Track-2-Artificial-Intelligence-AI-The-Next-Frontier

Regulatory Submissions, Information, and Document Management Forum

Session 10 Track 2: Artificial Intelligence (AI): The Next Frontier

    Session Chair(s)
      Brooke  Casselberry, MS, RAC

      Brooke Casselberry, MS, RAC

      • Owner
      • Cyan Life Sciences, United States
    This session will provide an overview of Artificial Intelligence (AI) technologies such as robotic process automation (RPA), natural language processing (NLP), and machine learning, and offer insight into how these AI technologies are developed and applied to regulatory affairs. Speakers will share their recent experience with implementing AI projects, their decision processes, and lessons learned along the way.
    Learning Objective : At the conclusion of this session, participants should be able to:
    • Define basic AI terminology
    • Provide examples of application to regulatory technology
    • Describe common challenges to implementing AI
      Adair  Turner, MSc, RAC

      Smart Regulatory Affairs: From Document Creation to Supported Decision-Making

      Adair Turner, MSc, RAC

      • Principal Consultant, Director Regulatory Operations
      • PharmaLex GmbH, Germany
      Nicholas  Drago, RAC

      Using Artificial Intelligence to Augment Regulatory Affairs Knowledge

      Nicholas Drago, RAC

      • Assistant Director, Regulatory Policy & Intelligence
      • Bayer Pharmaceuticals , United States
      Cesar  Vinces

      A Journey from Automation to AI within Regulatory Operations

      Cesar Vinces

      • Director, Head of U.S. & Canada Submissions Management, Regulatory Operations
      • Pfizer, Inc., United States